Scientists from the Broad Institute of Harvard and MIT, Lund University and Novartis today announced the discovery of three unsuspected regions of human DNA that contain clear genetic risk factors for type 2 diabetes, and another that is associated with elevated blood triglycerides.
Ten genetic variants associated with type 2 diabetes, a disease which impacts more than 170 million people worldwide, have been identified or confirmed by a US-Finnish team led by scientists at the University of Michigan School of Public Health.
Research increasingly shows promise to both slow and relieve the effects diabetic retinopathy, the most common complication of diabetes.
Researchers in Argentina have moved a step closer to combating diabetes by cloning four genetically modified cows capable of producing human insulin in their milk.
Eat right. Exercise. Monitor blood sugar. Take medication regularly. This is the advice physicians give the more than 20 million Americans affected with diabetes. Yet implementation of these recommendations is often far from ideal, putting patients at greater risk for damage to the heart, kidneys, eyes, and feet.
Researchers from the University of Washington, Rosalind Franklin University of Medicine and Science, Merck Laboratories, and Mount Sinai School of Medicine have released a study suggesting that specific laboratory and clinical tests can predict outcome of antibiotic therapy for infections in persons with diabetes.
Abbott Diabetes Care announced the launch of its FreeStyle Lite? blood glucose monitoring system for people with diabetes after receiving a 510(k) clearance from the U.S. Food and Drug Administration.
The high rate of diabetes among indigenous people is not due to their genetic heritage, according to a recently published study.
deCODE genetics, Inc. (Nasdaq:DCGN) announced the launch of deCODE T2?, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
A Northwestern University researcher has used adult stem cell injections to reset the immune systems of patients with early-onset Type 1 diabetes. After the therapy, patients no longer needed to take insulin for up to 35 months.